Ian R. Marsh

Also affiliated with Johns Hopkins Medicine

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Low-dose targeted radionuclide therapy renders immunologically cold tumors responsive to immune checkpoint blockade”.

Low-dose targeted radionuclide therapy renders immunologically cold tumors responsive to immune checkpoint blockade

Science Translational Medicine(2021)10.1126/scitranslmed.abb3631

N/A

0DataRank · unranked

233 citations

Reinier Hernandez, Peter M. Carlson, Joseph J. Grudzinski, Amber M. Bates, Justin C. Jagodinsky +17 more

Temporal analysis of type 1 interferon activation in tumor cells following external beam radiotherapy or targeted radionuclide therapy

Theranostics(2021)10.7150/thno.54881

N/A

0DataRank · unranked

80 citations

Won Jong Jin, Amber M. Bates, Reinier Hernandez, Joseph J. Grudzinski, Ian R. Marsh +19 more

Safety and feasibility of an in situ vaccination and immunomodulatory targeted radionuclide combination immuno-radiotherapy approach in a comparative (companion dog) setting

PLoS ONE(2021)10.1371/journal.pone.0255798

N/A

0DataRank · unranked

39 citations

Ian R. Marsh, Michelle Turek, Joseph J. Grudzinski, Eduardo Aluicio‐Sarduy, Jonathan W. Engle +13 more

Low-Dose Radiation Potentiates the Propagation of Anti-Tumor Immunity against Melanoma Tumor in the Brain after In Situ Vaccination at a Tumor outside the Brain

Radiation Research(2021)10.1667/rade-20-00237.1

N/A

0DataRank · unranked

21 citations

Raghava N. Sriramaneni, Amber M. Bates, Won Jong Jin, Justin C. Jagodinsky, Reinier Hernandez +15 more

Antitumor efficacy of 90Y-NM600 targeted radionuclide therapy and PD-1 blockade is limited by regulatory T cells in murine prostate tumors

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2022-005060

N/A

0DataRank · unranked

32 citations

Carolina A. Ferreira, Joseph J. Grudzinski, Christopher Massey, Eduardo Aluicio‐Sarduy, Jonathan W. Engle +7 more

Radiation to all macroscopic sites of tumor permits greater systemic antitumor response to in situ vaccination

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2022-005463

N/A

0DataRank · unranked

15 citations

Ravi B. Patel, Jen Birstler, Matthew Rodriquez, Claire Sun, Amy K. Erbe +12 more

Targeting of Head and Neck Cancer by Radioiodinated CLR1404 in Murine Xenograft Tumor Models with Partial Volume Corrected Theranostic Dosimetry

Cancer Biotherapy and Radiopharmaceuticals(2023)10.1089/cbr.2022.0084

N/A

0DataRank · unranked

1 citations

Chunrong Li, Joseph J. Grudzinski, Justin J. Jeffery, Colin A. Longhurst, David P. Adam +5 more

CD38‐Specific Gallium‐68 Labeled Peptide Radiotracer Enables Pharmacodynamic Monitoring in Multiple Myeloma with PET

Advanced Science(2024)10.1002/advs.202308617

N/A

0DataRank · unranked

18 citations

Kuldeep Gupta, Akhilesh Mishra, Gabriela Lofland, Ian R. Marsh, Dhiraj Kumar +7 more

Voxel-Level Dosimetry for Combined Iodine 131 Radiopharmaceutical Therapy and External Beam Radiation Therapy Treatment Paradigms for Head and Neck Cancer

International Journal of Radiation Oncology*Biology*Physics(2024)10.1016/j.ijrobp.2024.02.005

N/A

0DataRank · unranked

6 citations

Joseph J. Grudzinski, Ian R. Marsh, Patrick M. Hill, Steve Y. Cho, Tyler Bradshaw +6 more

Evaluation of VLA-4 (Integrin α4β1) as a Shared Target for Radiopharmaceutical Therapy across Solid Tumors

Molecular Cancer Therapeutics(2025)10.1158/1535-7163.mct-24-0370

N/A

0DataRank · unranked

8 citations

Harikrishnan Rajkumar, Woong Hee Lee, Kwamena E. Baidoo, Robert S. Edinger, George Diehl +16 more